World Equity Group, Inc. Gilead Sciences, Inc. Transaction History

World Equity Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jul 18, 2024	BUY	$71.58 - $87.29 $233,923 - $285,263	3,268 New	3,268 $239 Million
Q4 2023 Jul 22, 2024	SELL	$73.27 - $83.09 $102,138 - $115,827	-1,394 Reduced 27.67%	3,644 $295 Million
Q3 2023 Jul 22, 2024	BUY	$73.94 - $80.67 $372,509 - $406,415	5,038 New	5,038 $378 Million
Q2 2023 Aug 26, 2024	SELL	$76.01 - $86.7 $6.88 Million - $7.85 Million	-90,535 Closed	0 $0
Q1 2023 Aug 26, 2024	BUY	$77.31 - $88.08 $7 Million - $7.97 Million	90,535 New	90,535 $1.29 Billion
Q4 2022 Sep 06, 2024	SELL	$62.32 - $89.47 $38,139 - $54,755	-612 Reduced 15.06%	3,452 $296 Million
Q3 2022 Sep 06, 2024	BUY	$59.54 - $68.01 $241,970 - $276,392	4,064 New	4,064 $251 Million
Q2 2022 Sep 06, 2024	SELL	$57.72 - $65.01 $6,522 - $7,346	-113 Reduced 3.17%	3,457 $214 Million
Q1 2022 Sep 06, 2024	BUY	$57.92 - $72.58 $206,774 - $259,110	3,570 New	3,570 $212 Million

1,942

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $117B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of World Equity Group, Inc., based on Form 13F filings with the SEC.

Stay updated on World Equity Group, Inc. with notifications on news.